文献速递艾滋病与性传播感染

单剂与3剂苄星青霉素治疗HIV合并早期梅毒的随机对照试验

Single Dose Versus 3 Doses of Intramuscular Benzathine Penicillin for Early Syphilis in HIV: A Randomized Clinical Trial.
PubMed 文献 · Clin Infect Dis · 2017-01-01

意向性分析显示单剂组治疗成功率80%、3剂组93%,差异无统计学意义;符合方案分析分别为93%和100%。3剂方案未改善梅毒血清学结局,支持CDC推荐单剂方案。

要点

  • HIV合并早期梅毒患者单剂与3剂苄星青霉素G的血清学成功率无显著差异。
  • CD4计数、RPR滴度和梅毒分期不影响治疗结果。

核心结论

  • 与单剂苄星青霉素G相比,3剂方案未改善HIV合并早期梅毒患者的血清学结局。
  • 结果支持CDC推荐HIV感染者早期梅毒使用单剂苄星青霉素G。

研究设计与样本

  • 比较单剂与3剂肌注苄星青霉素G方案,每3个月监测RPR滴度。
  • 治疗成功定义为12个月随访期间RPR滴度下降≥2个稀释度(4倍)。

主要发现

  • CD4 T细胞计数、RPR滴度和梅毒分期不影响治疗结果。

关键数值与推荐

  • 单剂方案为肌注2.4百万单位苄星青霉素G。
  • 治疗成功标准为12个月内RPR滴度下降≥2个稀释度(4倍)。
  • 3剂方案与单剂方案的成功率差异无统计学意义。

临床怎么用

  • HIV合并早期梅毒患者可采用单剂苄星青霉素G治疗,无需常规升级为3剂。
  • 治疗后应每3个月监测RPR滴度以评估血清学应答。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients coinfected with syphilis and human immunodeficiency virus (HIV) may have a slower decrease in rapid plasma reagin (RPR) titers. Currently a single dose of 2.4 million units of intramuscular benzathine penicillin G (BPG) is recommended for the treatment of early syphilis. Some observational studies have suggested that this regimen may lead to high failure rates in coinfected patients. METHODS: We conducted an open-label randomized clinical trial to compare the efficacy of single-dose and 3-dose regimens of BPG for the treatment of early syphilis in HIV-infected individuals. RPR titers were monitored every 3 months. Treatment success was defined as a decrease in RPR titers of ≥2 dilutions (4-fold) during a 12-month follow-up period. RESULTS: Sixty-four patients were included. In the intention-to-treat analysis, treatment success rates were 80% (28 of 35 subjects) and 93% (27 of 29 subjects) in the single-dose and 3-dose regimens, respectively (absolute difference, 13% [95% confidence interval {CI}, -5% to 30%; P = .17). In the per-protocol analysis, success rates were 93% (27 of 29) and 100% in the single-dose and 3-dose regimens, respectively (absolute difference, 7% [95% CI, -7% to 22%]; P = .49). CD4 T-cell count, RPR titer and syphilis stage did not affect treatment results. CONCLUSIONS: When compared with a single dose of BPG, a 3-dose regimen did not improve syphilis serological outcomes. Our results support the Centers for Disease Control and Prevention recommendation of a single dose of BPG in HIV-infected patients with early syphilis. CLINICAL TRIALS REGISTRATION: NCT02611765.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Andrade R, Rodriguez-Barradas MC, Yasukawa K, et al. Single Dose Versus 3 Doses of Intramuscular Benzathine Penicillin for Early Syphilis in HIV: A Randomized Clinical Trial. Clin Infect Dis. 2017. PMID: 28200045. doi:10.1093/cid/ciw862

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。